La bourse est fermée

ResMed Inc. (RMD.AX)

ASX - ASX Prix différé. Devise en AUD
Ajouter à la liste dynamique
35,30-0,17 (-0,48 %)
À la clôture : 4:10PM AEDT

ResMed Inc.

9001 Spectrum Center Boulevard
San Diego, CA 92123
United States
858 836 5000

Secteur d’activitéMedical Instruments & Supplies
Employés à temps plein7 970

Dirigeants clés

NomTitrePayerExercéAnnée de naissance
Dr. Peter C. Farrell A.M., AM, B.E., BE (Hons), Ph.D., ScDFounder & Non-Exec. Chairman441,46kS.O.1942
Mr. Michael J. Farrell BE, MBA, SMCEO & Director2,69MS.O.1972
Mr. Robert A. DouglasPres & COO1,94M2,48M1960
Mr. Brett A. SandercockChief Financial Officer1,01MS.O.1967
Dr. James R. Hollingshead Ph.D.Pres of Sleep & Respiratory Care Bus.1,43MS.O.1963
Mr. Kaushik GhoshalPres of SaaS Bus. & CTOS.O.S.O.1968
Mr. David B. PendarvisChief Admin. Officer, Global Gen. Counsel & Corp. Sec.S.O.S.O.1959
Ms. Constance C. BienfaitDirector of Investor RelationsS.O.S.O.S.O.
Ms. Amy WakehamVP of Investor Relations & Corp. CommunicationsS.O.S.O.S.O.
Ms. Nupur BhushanChief People OfficerS.O.S.O.S.O.
Les montants ont été établis en date du 31 décembre 2021 et les valeurs de compensation concernent le dernier exercice fiscal clos à cette date. Le terme « rémunération » désigne le salaire, les bonus, etc. Le terme « exercé » est utilisé pour la valeur des options exercées au cours de l’exercice fiscal. Devise exprimée en AUD.


ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets. The company operates in two segments, Sleep and Respiratory Care, and Software as a Service. It offers various products and solutions for a range of respiratory disorders, including technologies to be applied in medical and consumer products, ventilation devices, diagnostic products, mask systems for use in the hospital and home, headgear and other accessories, dental devices, and cloud-based software informatics solutions to manage patient outcomes, as well as provides customer and business processes. The company also provides AirView, a cloud-based system that enables remote monitoring and changing of patients' device settings; myAir, a personalized therapy management application for patients with sleep apnea that provides support, education, and troubleshooting tools for increased patient engagement and improved compliance; U-Sleep, a compliance monitoring solution that enables home medical equipment (HME)to streamline their sleep programs; and connectivity module and propeller solutions. In addition, it offers out-of-hospital software solution, such as Brightree business management software and service solutions to providers of HME, pharmacy, home infusion, orthotics, and prosthetics services; MatrixCare care management and related ancillary solutions to senior living, skilled nursing, life plan communities, home health, home care, and hospice agencies, as well as related accountable care organizations; and HEALTHCAREfirst that offers electronic health record, software, billing and coding services, and analytics for home health and hospice agencies. The company markets its products primarily to sleep clinics, home healthcare dealers, and hospitals through a network of distributors and direct sales force in approximately 140 countries. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California.

Gouvernance d’entreprise

L’ISS Governance QualityScore de ResMed Inc. en date du 26 septembre 2021 est 5. Les scores principaux sont Audit : 3; Société : 6; Droits des actionnaires : 5; Compensation : 6.

Résultats de gouvernance d’entreprise offerts par Institutional Shareholder Services (ISS). Les résultats indiquent un rang décile par rapport à l’indice ou à la région. Un résultat décile de 1 indique un risque de gouvernance faible, tandis que 10 indique un risque de gouvernance élevé.